369 related articles for article (PubMed ID: 8433635)
1. Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
Krahn M; Detsky AS
Med Decis Making; 1993; 13(1):4-20. PubMed ID: 8433635
[TBL] [Abstract][Full Text] [Related]
2. An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
Harris A; Yong K; Kermode M
Aust N Z J Public Health; 2001 Jun; 25(3):222-9. PubMed ID: 11494989
[TBL] [Abstract][Full Text] [Related]
3. Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation.
Tilson L; Thornton L; O'Flanagan D; Johnson H; Barry M
Eur J Public Health; 2008 Jun; 18(3):275-82. PubMed ID: 18160389
[TBL] [Abstract][Full Text] [Related]
4. An economic evaluation of universal infant vaccination strategies against hepatitis B in Thailand: an analytic decision approach to cost-effectiveness.
Vimolket T; Poovorawan Y
Southeast Asian J Trop Med Public Health; 2005 May; 36(3):693-9. PubMed ID: 16124440
[TBL] [Abstract][Full Text] [Related]
5. Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: an experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalence.
Hung HF; Chen TH
Vaccine; 2009 Nov; 27(48):6770-6. PubMed ID: 19735755
[TBL] [Abstract][Full Text] [Related]
6. A reappraisal of hepatitis B virus vaccination strategies using cost-effectiveness analysis.
Bloom BS; Hillman AL; Fendrick AM; Schwartz JS
Ann Intern Med; 1993 Feb; 118(4):298-306. PubMed ID: 8420448
[TBL] [Abstract][Full Text] [Related]
7. Cost-effectiveness analysis of hepatitis B vaccine booster in children born to HBsAg-positive mothers in rural China.
Wang Y; Shi JF; Wang L; Yan Y; Yao H; Dai M; Chen T; Qu C
Int J Infect Dis; 2019 Jan; 78():130-139. PubMed ID: 30466898
[TBL] [Abstract][Full Text] [Related]
8. [Analysis on economic efficacy regarding previous strategies and current recommendations for vaccination against hepatitis B virus in China].
Zhang SX; Dang RB; Zhang WD; Liang XF; Cui FQ
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Oct; 29(10):1003-8. PubMed ID: 19173882
[TBL] [Abstract][Full Text] [Related]
9. Clinical and economic impact of a combination Haemophilus influenzae and Hepatitis B vaccine: estimating cost-effectiveness using decision analysis.
Fendrick AM; Lee JH; LaBarge C; Glick HA
Arch Pediatr Adolesc Med; 1999 Feb; 153(2):126-36. PubMed ID: 9988242
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations.
Margolis HS; Coleman PJ; Brown RE; Mast EE; Sheingold SH; Arevalo JA
JAMA; 1995 Oct; 274(15):1201-8. PubMed ID: 7563509
[TBL] [Abstract][Full Text] [Related]
11. Selective Hepatitis B Birth-Dose Vaccination in São Tomé and Príncipe: A Program Assessment and Cost-Effectiveness Study.
Hagan JE; Carvalho E; Souza V; Queresma Dos Anjos M; Abimbola TO; Pallas SW; Tevi Benissan MC; Shendale S; Hennessey K; Patel MK
Am J Trop Med Hyg; 2019 Oct; 101(4):891-898. PubMed ID: 31392947
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B vaccination in children: the Taiwan experience.
Ni YH; Chen DS
Pathol Biol (Paris); 2010 Aug; 58(4):296-300. PubMed ID: 20116181
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness of active-passive prophylaxis and antiviral prophylaxis during pregnancy to prevent perinatal hepatitis B virus infection.
Fan L; Owusu-Edusei K; Schillie SF; Murphy TV
Hepatology; 2016 May; 63(5):1471-80. PubMed ID: 26509655
[TBL] [Abstract][Full Text] [Related]
14. [Economic evaluation of various hepatitis B vaccination Strategies in Switzerland].
Zurn P; Danthine JP
Soz Praventivmed; 1998; 43 Suppl 1():S61-4, S134-7. PubMed ID: 9833269
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies.
Wiebe T; Fergusson P; Horne D; Shanahan M; Macdonald A; Heise L; Roos LL
Med Decis Making; 1997; 17(4):472-82. PubMed ID: 9343806
[TBL] [Abstract][Full Text] [Related]
16. A cost-effectiveness analysis of hepatitis B vaccine in predialysis patients.
Oddone EZ; Cowper PA; Hamilton JD; Feussner JR
Health Serv Res; 1993 Apr; 28(1):97-121. PubMed ID: 8463111
[TBL] [Abstract][Full Text] [Related]
17. Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents.
Levaux HP; Schonfeld WH; Pellissier JM; Cassidy WM; Sheriff SK; Fitzsimon C
Pediatrics; 2001 Aug; 108(2):317-25. PubMed ID: 11483794
[TBL] [Abstract][Full Text] [Related]
18. [Decision tree and cost-benefit analysis on strategies related to preventing maternal-infantile transmission of hepatitis B virus infection].
Shi G; Zhang SX
Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Mar; 34(3):273-8. PubMed ID: 23759236
[TBL] [Abstract][Full Text] [Related]
19. Economic evaluation of infant and adolescent hepatitis B vaccination in the UK.
Siddiqui MR; Gay N; Edmunds WJ; Ramsay M
Vaccine; 2011 Jan; 29(3):466-75. PubMed ID: 21073988
[TBL] [Abstract][Full Text] [Related]
20. Benefits of early hepatitis B immunization programs for newborns and infants.
Van Herck K; Van Damme P
Pediatr Infect Dis J; 2008 Oct; 27(10):861-9. PubMed ID: 18776823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]